1L aRCC - Changing the Treatment Paradigm

IO+Anti-VEGF Combinations

Brian I. Rini, MD. FACP

Professor of Medicine
Leader, GU Program
Department of Hematology and Oncology
Cleveland Clinic Taussig Cancer Institute
Glickman Urological and Kidney Institute

Wednesday, July 24^th 17:00-20:00
NYX Hotel, Herzliya

AGENDA

Event Moderator: Dr. Daniel Keizman

17:00-17:30 Gathering & refreshments
17:30-18:00 Rationalizing the combination of angiogenesis inhibitors with PD-1 blockade
Prof. Gal Markel
18:00-18:40 IO+Anti-VEGF therapy in 1L aRCC - Current and future perspectives
Brian Rini, MD. FACP
18:40-19:20 Case presentation and patient management in IO+Anti-VEGF therapy
Brian Rini, MD. FACP
19:20-20:00 Q&A with Dr. Brian Rini & Prof. Gal Markel
20:00 Dinner

Please select 1-2 topics that interest you the most:

Scientific and Clinical Rationale for IO+Anti-VEGF combinations

Treatment Selection in 1L aRCC

Patient Profile Management in IO+Anti-VEGF Therapy

Anti PD-1 vs. Anti PD-L1

Adjuvant Therapy in RCC

I agree to receive promotional material from MSD via emails, text messages (SMS) and/or other communication means. I agree that my information will be stored in MSD’s customers’ database and be used for the purposes defined in the

privacy notice. Please note that the information is provided to MSD of your own free will and that you are not legally obligated to provide such information. The information about you will be stored in the MSD databases and will be used by MSD to maintain contact with you, to provide additional services in the future, and to contact you regarding issues related to your area of expertise and to MSD, its products and relevant events, while complying with the law and the ethical rules. The information may be transferred to companies related to MSD and to its suppliers in Israel and abroad for the same purposes and will be treated while protecting your privacy according to MSD standards. If you wish to update the information or to be deleted from our database, you may contact us at any time at
DPOC-ISRAEL@merck.com.

I declare that I am a healthcare professional.

1L aRCC - Changing the Treatment Paradigm

IO+Anti-VEGF Combinations

Brian I. Rini, MD. FACP

Wednesday, July 24th 17:00-20:00 NYX Hotel, Herzliya

AGENDA

Wednesday, July 24^th 17:00-20:00
NYX Hotel, Herzliya